Multicenter experience shows comparable oncological outcomes using a new robotic system in prostate cancer surgery, suggesting its viability.
Results of our experience with RARP suggest that performing RARP using VRSS oncologic results are comparable with other case studies using other robotic platforms.
No takes yet. Share an insight, caveat, or question.
Meneghetti et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: